Soleno Therapeutics, Inc. (SLNO)
NASDAQ: SLNO · Real-Time Price · USD
63.76
-1.80 (-2.75%)
At close: Oct 10, 2025, 4:00 PM EDT
62.48
-1.28 (-2.00%)
After-hours: Oct 10, 2025, 7:42 PM EDT

Soleno Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202013 - 2019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2013 - 2019
3,3882,0541,27581164768
Upgrade
Market Cap Growth
78.69%61.12%1478.46%-50.66%-78.69%17.03%
Upgrade
Enterprise Value
3,1471,8151,10566.18142.59719.07
Upgrade
Last Close Price
63.7644.9540.259.9030.75144.75
Upgrade
PE Ratio
--10.26-17.06-3.45-5.29-24.74
Upgrade
Forward PE
49.46-----
Upgrade
PB Ratio
13.398.388.107.819.2016.87
Upgrade
P/TBV Ratio
12.117.374.218.039.1913.27
Upgrade
P/FCF Ratio
--29.64-51.12-3.88-5.89-30.45
Upgrade
P/OCF Ratio
--29.73-51.12-3.89-5.90-30.46
Upgrade
EV/EBITDA Ratio
--9.78-28.04-2.95-4.82-20.94
Upgrade
EV/EBIT Ratio
--9.67-26.71-2.71-4.52-19.82
Upgrade
EV/FCF Ratio
--26.19-44.33-3.18-5.13-28.50
Upgrade
Debt / Equity Ratio
0.220.210.0000.010
Upgrade
Debt / EBITDA Ratio
-0.28-0.28-0.01-0.01-0.010.00
Upgrade
Debt / FCF Ratio
-0.62-0.76-0.02-0.01-0.02-0.01
Upgrade
Quick Ratio
14.8715.5514.752.002.665.71
Upgrade
Current Ratio
15.1315.6814.892.142.805.83
Upgrade
Return on Equity (ROE)
-73.41%-87.35%-46.45%-171.05%-97.60%-81.46%
Upgrade
Return on Assets (ROA)
-57.77%-73.36%-39.95%-78.64%-62.72%-70.36%
Upgrade
Return on Capital (ROIC)
-536.20%-728.72%-365.42%-193.44%-218.87%-221.35%
Upgrade
Return on Capital Employed (ROCE)
-61.45%-77.97%-43.94%-104.42%-75.15%-81.03%
Upgrade
Earnings Yield
-5.34%-9.74%-5.86%-28.99%-18.89%-4.04%
Upgrade
FCF Yield
-2.49%-3.37%-1.96%-25.74%-16.98%-3.28%
Upgrade
Buyback Yield / Dilution
-0.35%-7.94%-14.12%-17.45%0.07%-6.99%
Upgrade
Total Shareholder Return
--7.94%-14.12%-17.45%0.07%-6.99%
Upgrade
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q